<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/abel/Downloads/grobid-0.5.6/grobid-home/schemas/xsd/Grobid.xsd" xml:space="preserve">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins</title>
			</titleStmt>
			<publicationStmt>
				<publisher />
				<availability status="unknown"><licence /></availability>
				<date type="published" when="2014-07-26">Available online 26 July 2014</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sheng-Fan</forename><surname>Wang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medical Laboratory Science and Biotechnology</orgName>
								<orgName type="institution">Kaohsiung Medical University</orgName>
								<address>
									<settlement>Kaohsiung</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute of Biomedical Sciences</orgName>
								<orgName type="institution">Academia Sinica</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Center for Infectious Disease and Cancer Research</orgName>
								<orgName type="institution">Kaohsiung Medical University</orgName>
								<address>
									<settlement>Kaohsiung</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sung-Pin</forename><surname>Tseng</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medical Laboratory Science and Biotechnology</orgName>
								<orgName type="institution">Kaohsiung Medical University</orgName>
								<address>
									<settlement>Kaohsiung</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chia-Hung</forename><surname>Yen</surname></persName>
							<affiliation key="aff2">
								<orgName key="dep1" type="department">Graduate Institute of Natural Products</orgName>
								<orgName key="dep2" type="department">College of Pharmacy</orgName>
								<orgName type="institution">Kaohsiung Medical University</orgName>
								<address>
									<settlement>Kaohsiung</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jyh-Yuan</forename><surname>Yang</surname></persName>
							<affiliation key="aff3">
								<orgName key="dep1" type="department">Center for Research</orgName>
								<orgName key="dep2" type="department">Diagnostics and Vaccine Development</orgName>
								<orgName key="dep3" type="department">Centers for Disease Control</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ching-Han</forename><surname>Tsao</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Biomedical Sciences</orgName>
								<orgName type="institution">Academia Sinica</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chun-Wei</forename><surname>Shen</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Office of Occupational Safety and Health</orgName>
								<orgName type="institution">Kaohsiung Municipal Ta-Tung Hospital</orgName>
								<address>
									<settlement>Kaohsiung</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kuan-Hsuan</forename><surname>Chen</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Center for Infectious Disease and Cancer Research</orgName>
								<orgName type="institution">Kaohsiung Medical University</orgName>
								<address>
									<settlement>Kaohsiung</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fu-Tong</forename><surname>Liu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Biomedical Sciences</orgName>
								<orgName type="institution">Academia Sinica</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wu-Tse</forename><surname>Liu</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Biotechnology and Laboratory Science in Medicine</orgName>
								<orgName type="institution">National Yang-Ming University</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yi-Ming</forename><forename type="middle">Arthur</forename><surname>Chen</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Center for Infectious Disease and Cancer Research</orgName>
								<orgName type="institution">Kaohsiung Medical University</orgName>
								<address>
									<settlement>Kaohsiung</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName key="dep1" type="department">Department of Microbiology</orgName>
								<orgName key="dep2" type="department">College of Medicine</orgName>
								<orgName type="institution">Kaohsiung Medical University</orgName>
								<address>
									<settlement>Kaohsiung</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jason</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Biotechnology and Laboratory Science in Medicine</orgName>
								<orgName type="institution">National Yang-Ming University</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="laboratory">AIDS Prevention and Research Center</orgName>
								<orgName type="institution">National Yang-Ming University</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2014-07-26">Available online 26 July 2014</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1016/j.bbrc.2014.07.090</idno>
					<note type="submission">Article history: Received 5 July 2014</note>
					<note>a r t i c l e i n f o</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>

		<encodingDesc>
			<appInfo>
				<application ident="GROBID" version="0.5.6" when="2020-03-16T22:29+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>		<profileDesc>
			<textClass>
				<keywords>Antibody-dependent enhancement Anti-spike antibody Fc receptors HL-CZ SARS-CoV</keywords>
			</textClass>
			<abstract>
<div><head>a b s t r a c t</head><p>The severe acute respiratory syndrome coronavirus (SARS-CoV) still carries the potential for reemergence, therefore efforts are being made to create a vaccine as a prophylactic strategy for control and prevention. Antibody-dependent enhancement (ADE) is a mechanism through which dengue viruses, feline coronaviruses, and HIV viruses take advantage of anti-viral humoral immune responses to infect host target cells. Here we describe our observations of SARS-CoV using ADE to enhance the infectivity of a HL-CZ human promonocyte cell line. Quantitative-PCR and immunofluorescence staining results indicate that SARS-CoV is capable of replication in HL-CZ cells, and of displaying virus-induced cytopathic effects and increased levels of TNF-a, IL-4 and IL-6 two days post-infection. According to flow cytometry data, the HL-CZ cells also expressed angiotensin converting enzyme 2 (ACE2, a SARS-CoV receptor) and higher levels of the FccRII receptor. We found that higher concentrations of anti-sera against SARS-CoV neutralized SARS-CoV infection, while highly diluted anti-sera significantly increased SARS-CoV infection and induced higher levels of apoptosis. Results from infectivity assays indicate that SARS-CoV ADE is primarily mediated by diluted antibodies against envelope spike proteins rather than nucleocapsid proteins. We also generated monoclonal antibodies against SARS-CoV spike proteins and observed that most of them promoted SARS-CoV infection. Combined, our results suggest that antibodies against SARS-CoV spike proteins may trigger ADE effects. The data raise new questions regarding a potential SARS-CoV vaccine, while shedding light on mechanisms involved in SARS pathogenesis.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div><head n="1.">Introduction</head><p>Coronaviruses are enveloped viruses with positive stranded, capped, and poly-adenylated RNA genomes ranging between 28 and 32 kb </p><p>The SARS-CoV genome consists of 28 putative open reading frames (ORFs) in 9 mRNA transcripts. </p><p>Several vaccine strategies under study target SARS-CoV spike genes or proteins to induce neutralizing and protective antibodies. However, a significant concern is that vaccinations against different kinds of coronaviruses have markedly different outcomes </p><p>We used SARS-CoV clinical isolates and pseudotyped viruses to determine whether ADE occurs during SARS-CoV infection. Our experiments involved a human promonocyte cell line, HL-CZ, that has not yet been reported for SARS-CoV infections. According to our data, HL-CZ cells express ACE2 and FcRII receptors, and can be infected by SARS-CoV. We also noted that diluted anti-sera against SARS-CoV promotes SARS-CoV infection, and that this phenomenon is significantly mediated by anti-S antibodies. Finally, only one of several monoclonal antibodies against S proteins generated for this project expressed neutralizing action; the others displayed mild-to-moderate ADE effects on HL-CZ cells.</p></div>
<div><head n="2.">Materials and methods</head></div>
<div><head n="2.1.">Ethics statement</head><p>Approval for obtaining sera from SARS-CoV patients was applied for and received from the Institutional Ethics Committee of National Yang-Ming University. All procedures were conducted according to committee rules.</p></div>
<div><head n="2.2.">Cell lines, viruses and anti-sera</head><p>Five cell lines were used: HL-CZ human promonocyte isolated from a leukemia patient </p></div>
<div><head n="2.3.">Infectivity and neutralization assays</head><p>HL-CZ or Vero-E6 cells (1 &#194; 10 5 /well) were used in direct infection assays. SARS-CoV or pseudotyped viruses (MOI = 0.1) were incubated with cells for 2 h at 37&#176;C in serum-free medium and washed with PBS. Following incubation, 2 ml of RPMI or DMEM medium containing 10% serum and 1X (100 IU penicillin and 100 lg/mL streptomycin) antibiotics were added, followed by another incubation in 5% CO 2 at 37&#176;C for different lengths of time. Viral supernatants and infected cell lysates and were collected and subjected to quantitative RT-PCR analyses aimed at the ORFIb region </p></div>
<div><head n="2.4.">Real-time RT-PCR</head><p>Viral RNA was extracted from culture supernatant using a QIAamp Viral RNA Mini Kit (Qiagen). The two real-time RT-PCR primer sets used to measure mRNAs were CDC-2 forward and reverse (nucleocapsid; U.S. CDC catalogue #KT0051) </p></div>
<div><head n="2.5.">Flow cytometry and immunofluorescence staining</head><p>Cells were harvested and held for 30 min at 4&#176;C in PBS containing 1% FBS, followed by another 30 min of incubation at 4&#176;C with isotype-matched control or monoclonal antibodies (1 lg/ml) for each indicated human Fc receptor. Immunofluorescence staining procedures are described in </p></div>
<div><head n="2.6.">SARS-CoV S and N protein preparation</head><p>A Taiwanese SARS-CoV isolate TW1 strain (GenBank accession No. AY291451) was used as a template to clone and amplify nucleocapsid and spike genes using plasmids expressed in the prokaryote system. Details and schemes are described in the Supplemental file; see especially S-Figs. 2 and 3 </p></div>
<div><head n="2.7.">Generation of monoclonal or polyclonal antibodies against SARS-CoV S and N proteins</head><p>Our procedures for generating monoclonal or polyclonal antibodies are the same as those described in </p></div>
<div><head n="2.8.">Apoptosis assays</head><p>HL-CZ cell apoptosis assays were performed using Annexin V staining.</p></div>
<div><head n="2.9.">Immunoblotting</head><p>HL-CZ or Vero-E6 cells were infected with SARS-CoV and incubated at 37&#176;C for 48-72 h. Culture supernatants were concentrated by ultracentrifugation at 25,000 rpm for 2.5 h and lysed in SDS-PAGE sample buffer. SDS-PAGE electrophoresis was performed according to the protocols given in </p></div>
<div><head n="2.10.">Antibody-dependent enhancement assays</head><p>Assay details are as previously described </p></div>
<div><head n="2.11.">Statistical analyses</head><p>All experiments were performed a minimum of three times. GraphPad Prism software was used for all statistical analyses. Statistical significance (p &lt; 0.05) was calculated using unpaired Student's t-tests.</p></div>
<div><head n="3.">Results</head></div>
<div><head n="3.1.">Susceptibility of HL-CZ cells to SARS-CoV infection</head><p>Previous researchers have infected HL-CZ human promonocyte cells with HIV-1 and dengue viruses, among several others </p><p>3.2. HL-CZ cells express angiotensin-converting enzyme 2 (ACE 2) and Fcc receptors, and display antibody-dependent SARS-CoV infectivity ACE2 is a functional SARS-CoV receptor that is abundant in human lung and small intestine epithelial cells </p><p>We tried to determine if this antibody-dependent enhancement also occurred in SARS-CoV-infected HL-CZ cells. Our data indicate that treatment with anti-sera collected from SARS-CoV patients and diluted 1000-to 2000-fold resulted in increased virus infectivity and CPE compared to treatment with 10-fold diluted anti-sera </p></div>
<div><head n="3.3.">Antibody-dependent SARS-CoV enhancement is mediated by antispike antibodies</head><p>Our next task was to determine which antibody promoted SARS-CoV infection. We noted that antibodies against S and N proteins were produced at high levels during SARS-CoV infections, and therefore used S-and N-protein-recognizing antibodies to detect early SARS-CoV infections. After generating mouse antibodies against S and N recombinant proteins (Supplemental </p><p>A series of monoclonal antibodies (mAbs) against spike proteins was generated to confirm this finding (Supplemental </p></div>
<div><head n="4.">Discussion</head><p>While the generation of protective antibodies against specific proteins is a useful strategy for microbial disease control, some immune responses to pathogens can have deleterious effectsfor example, cytokine storms associated with avian influenza virus, and increased mortality from SARS-CoV infections. Cell infection via antibody-dependent enhancement has been observed for several viral diseases, including dengue virus, HIV-1, and feline infectious peritonitis virus (FIPV) </p><p>Currently there are no licensed vaccines against human coronaviruses. For animals, vaccines have been generated against several, including the transmissible gastroenteritis virus </p><p>We found that higher concentrations of anti-sera collected from SARS-CoV-infected patients (10-to 100-fold dilution) displayed greater viral neutralization capability compared to more diluted concentrations (1000-to 2000-fold), which facilitated SARS-CoV infection and induced higher levels of virus-induced apoptosis </p><p>In this study we identified an alternative susceptible cell line, HL-CZ, for future SARS-CoV research, and found that ADE associated with SARS-CoV infection is primarily mediated by anti-spike antibodies. It is our hope that this information will be useful in the development of a human SARS-CoV vaccine, as well as in research involving immune-mediated infections tied to SARS pathogenesis. </p></div><figDesc>HL-CZ cells are susceptible to SARS-CoV infection. After infecting cells with SARS-CoV, culture supernatant and cell lysates were collected for (A) SARS-CoV detection and (B) cellular cytokine mRNA expression. (C) Results from HL-CZ cytopathic effect observation and immunofluorescence staining 2 d post-infection. (D) Supernatants from mock and SARS-CoV-infected HL-CZ cells were used to infect Vero-E6 cells for 2 d. Results are from one representative experiment of the three performed.</figDesc><figDesc>HL-CZ cells express ACE2 and Fc receptors, and display antibody-dependent enhancement. (A) Results from flow cytometry analyses of Fc receptors and ACE2 expression in HL-CZ cells. (B) SARS-CoV or mock infections in the presence of various dilutions of anti-sera drawn from SARS-CoV patients. (C) Transmission electron microscopy images of HL-CZ cells infected with SARS-CoV in the presence of various dilutions of anti-sera against SARS-CoV. Images 1 and 3 indicate 10-, and 2000-fold dilutions of anti-sera against SARS-CoV, respectively. Image 2 indicates 10-fold dilutions of normal sera control treatment.</figDesc><figDesc>Antibody-dependent enhancement of SARS-CoV infection is mediated by anti-spike protein antibodies. (A) Results from infectivity assays using HL-CZ cells infected with SARS-CoV and treated with various dilutions of anti-sera collected from SARS-CoV patients. (B) Apoptosis analyses of HL-CZ cells infected with SARS-CoV in the presence of 1000-fold diluted normal sera and anti-SARS-CoV sera (Annexin V staining). (C) HL-CZ cells infected with SARS-CoV in the presence of various dilutions (10-, 100-, 1000-or 2000-fold) of mouse anti-spike protein serum and isotype control mouse serum. (D) HL-CZ cells infected with SARS-CoV in the presence of different dilutions (10-, 100-, 1000or 2000-fold) of mouse anti-nucleocapsid serum and isotype control mouse serum. C, normal sera (control); S, anti-SARS sera (sample). Shown are results from one representative experiment of three performed ( &#8260; p &lt; 0.05; &#8260;&#8260; p &lt; 0.01).</figDesc><figDesc>Monoclonal antibodies against the SIa regions of spike proteins show antibody-dependent enhancement capability. (A) Isotype and epitope mapping of monoclonal antibodies against SARS-CoV spike proteins (NI &#8260; , not identified; bold, conservative amino acid residues). Lower part, fragment scheme of spike proteins used to generate monoclonal antibodies. (B) Evaluations of ADE effects of SARS-CoV-pseudotyped virus infections of HL-CZ cells in the presence of the monoclonal antibodies listed in (A). (C) Infectivity assays were performed using SARS-CoV-infected HL-CZ cells treated with SIb4, SIb2, or isotype control antibodies. (D) Cytopathic effects observed in HL-CZ cells treated with SIb4, SIb2, or isotype control antibodies. Presented results are from one representative experiment of three performed ( &#8260; p &lt; 0.05; &#8260;&#8260; p &lt; 0.01).</figDesc><figDesc>and ORF1b, which http://dx.doi.org/10.1016/j.bbrc.2014.07.090 0006-291X/&#211; 2014 Elsevier Inc. All rights reserved.</figDesc></body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgments</head><p>The authors wish to thank their colleagues at the AIDS Prevention and Research Center of National Yang-Ming University and the Center of Infectious Disease and Cancer Research of Kaohsiung Medical University for their assistance and useful discussions. This research was supported by Grants from the National Science Council, Republic of China (NSC 101-2320-B-010-055-MY3).</p></div>
			</div>

			<div type="annex">
<div><head>Appendix A. Supplementary data</head><p>Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.bbrc.2014.07.090.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
				<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Hsueh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">SARS outbreak in Taiwan</title>
		<imprint>
			<date type="published" when="2004" />
			<biblScope unit="volume">10</biblScope>
			<biblScope from="1515" to="1516" unit="page" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Antibody detection of SARS-CoV spike and nucleocapsid protein</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Y</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Jan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope from="931" to="936" unit="page" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Shih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Chu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Microbiol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope from="359" to="365" unit="page" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus</title>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Vasilieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Berne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Somasundaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Luzuriaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Greenough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Choe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Farzan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">426</biblScope>
			<biblScope from="450" to="454" unit="page" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Antibody-mediated protection against mucosal simianhuman immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Barnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Legg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goodsell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zur Megede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Polo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Donnelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ulmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Otten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vajdy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Srivastava</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope from="5975" to="5985" unit="page" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Chem</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope from="988" to="995" unit="page" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Antibody-dependent enhancement of virus infection and disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Tirado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Yoon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Viral Immunol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope from="69" to="86" unit="page" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">V</forename><surname>Corapi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Ngichabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Baines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Scott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope from="956" to="965" unit="page" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Isolation of dengue virus with a human promonocyte cell line</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Ko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Trop. Med. Hyg</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope from="494" to="499" unit="page" />
			<date type="published" when="1991" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Hsueh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Hsiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Kao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope from="1163" to="1167" unit="page" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Shih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope from="10315" to="10324" unit="page" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Hsiung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Juang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope from="293" to="296" unit="page" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Chau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope from="561" to="566" unit="page" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thitithanyanont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope from="691" to="696" unit="page" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody</title>
		<author>
			<persName><forename type="first">A</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Daidoji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Koma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">C</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yasunaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ikuta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nakaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope from="197" to="202" unit="page" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jaume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Yip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Kam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dutry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Escriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Daeron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bruzzone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Subbarao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Peiris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Altmeyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hong Kong Med. J</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope from="31" to="36" unit="page" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH-and cysteine protease-independent FcgammaR pathway</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jaume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Yip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dutry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Callendret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Escriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Altmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Daeron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bruzzone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Peiris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope from="10582" to="10597" unit="page" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Hamming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Timens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bulthuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Lely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Navis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Goor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Pathol</title>
		<imprint>
			<biblScope unit="volume">203</biblScope>
			<biblScope from="631" to="637" unit="page" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">SARS-coronavirus replication in human peripheral monocytes/macrophages</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Harcourt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Hickman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcgrew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Goldsmith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Bellini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virus Res</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope from="93" to="101" unit="page" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Upregulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway</title>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>She</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virus Res</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope from="1" to="8" unit="page" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Tseng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope from="3039" to="3048" unit="page" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Immune response of sows vaccinated with attenuated transmissible gastroenteritis virus (TGEV) and recombinant TGEV spike protein vaccines and protection of their suckling pigs against virulent TGEV challenge exposure</title>
		<author>
			<persName><forename type="first">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sestak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Hodgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Shoup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Jackwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Saif</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Vet. Res</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope from="1002" to="1008" unit="page" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Gollins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Porterfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Gen. Virol</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope from="1261" to="1272" unit="page" />
			<date type="published" when="1984" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Complementmediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Robinson</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Montefiori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Gillespie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Mitchell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Acquir. Immune Defic. Syndr</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope from="33" to="42" unit="page" />
			<date type="published" when="1989" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Evaluation of antibody-dependent enhancement of feline infectious peritonitis virus infectivity using in situ hybridization</title>
		<author>
			<persName><forename type="first">C</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Scott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Microb. Pathog</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope from="275" to="285" unit="page" />
			<date type="published" when="1993" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
				<author>
			<persName><forename type="first">M</forename><surname>Zhu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">SARS immunity and vaccination</title>
		<imprint>
			<date type="published" when="2004" />
			<biblScope unit="volume">1</biblScope>
			<biblScope from="193" to="198" unit="page" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Kam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Lamirande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Guarner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Subbarao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peiris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Altmeyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope from="729" to="740" unit="page" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>